Cargando…

Comment on: ‘A new era for giant cell arteritis’

Detalles Bibliográficos
Autor principal:	Ing, Edsel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608356/ https://www.ncbi.nlm.nih.gov/pubmed/31767963 http://dx.doi.org/10.1038/s41433-019-0701-y

Ejemplares similares

Response to ‘Comment on: ‘A new era for giant cell arteritis’’
por: Mollan, S. P., et al.
Publicado: (2019)

Comment on: ‘Giant cell arteritis in patients of Indian subcontinental descent in the UK’
por: Vassallo, James, et al.
Publicado: (2019)

Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study
por: Ing, Edsel B, et al.
Publicado: (2018)

Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022)

Bilateral Arteritic Anterior Ischemic Optic Neuropathy Associated with Giant Cell Arteritis in Korea
por: Yoon, Hyeon-Jeong, et al.
Publicado: (2017)

Multivariable prediction model for suspected giant cell arteritis: development and validation
por: Ing, Edsel B, et al.
Publicado: (2017)

Arteritic Anterior Ischemic Optic Neuropathy Associated with Giant Cell Arteritis in an Elderly Korean Man
por: Kang, Yeon-Soo, et al.
Publicado: (2016)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Mazumder, Rifat, et al.
Publicado: (2021)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis. Reply
por: Karabayas, Maira
Publicado: (2021)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150
por: Cadiou, Simon, et al.
Publicado: (2022)

Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation
por: Ing, Edsel B, et al.
Publicado: (2019)

Comment on: Diagnostic positron emission tomography–computed tomography in clinically elusive giant cell arteritis
por: Gupta, Sonali, et al.
Publicado: (2018)

Comment on redefining authorship in the era of artificial intelligence: balancing ethics, transparency, and progress
por: Scimeca, Manuel, et al.
Publicado: (2023)

Tozinameran: New-onset giant cell arteritis: case report
Publicado: (2022)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Giant Cell Arteritis and Cardiac Comorbidity
por: Arias, Magela, et al.
Publicado: (2021)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022)

Treatment of Giant Cell Arteritis (GCA)
por: Régent, Alexis, et al.
Publicado: (2022)

An Unusual Case of Giant Cell Arteritis
por: Goyal, Nitasha, et al.
Publicado: (2022)

Evolution of ultrasound in giant cell arteritis
por: Kirby, Colm, et al.
Publicado: (2022)

Cardiovascular lesions in giant cell arteritis
por: Dzhus, Marta, et al.
Publicado: (2022)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Response to comment on: Diagnostic positron emission tomography-computed tomography in clinically elusive giant cell arteritis
por: Mohamed, Ryian
Publicado: (2018)

Mönckeberg sclerosis with giant cells as a masquerade of giant cell arteritis
por: Johannemann, Andrew, et al.
Publicado: (2021)

Clinical Images: Pulmonary Arteritis in Clinically Occult Aneurysmal Giant Cell Arteritis
por: Johnson, Victoria L, et al.
Publicado: (2021)

Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin?
por: Mortensen, Peter W., et al.
Publicado: (2022)

Answer to Cadiou et al. “SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?”. Joint Bone Spine 2021;88:105282
por: Manzo, Ciro, et al.
Publicado: (2022)

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply
por: Esen, Idil, et al.
Publicado: (2022)

Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets
por: Koster, Matthew J., et al.
Publicado: (2017)

Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021)

Advantages in diagnosis of giant cell arteritis by ultrasound
por: Wojczal, Joanna, et al.
Publicado: (2019)

Giant cell arteritis: early diagnosis is key
por: Baig, Iyza F, et al.
Publicado: (2019)

Ortner’s syndrome due to giant cell arteritis
por: Lamas, Edgar Stroppa
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_89oji7m0ps2h69ekm44jntlm42